Table IV.
Oncological outcomes in peer-reviewed literature for the surgical treatment of pathological femur fractures.
| Results/outcomes | ||||||
|---|---|---|---|---|---|---|
| Authors, year | Level of evidence | Surgical strategy | Anatomic site(s) | Median survival, months | Survival rate (1 year/2 year/3 year), % | (Refs.) |
| Sarahrudi et al, 2009 | III | IMN (n=94) | Femur | 3.7 | 17.0/6.0a | (7) |
| EPR (n=23) | ||||||
| ORIF (n=22) | ||||||
| Sarahrudi et al, 2006 | III | IMN (n=53) | Femur; humerus | 3.2 | 16.2/7.0/4.5 | (12) |
| EPR (n=18) | ||||||
| ORIF (n=13) | ||||||
| Wedin and Bauer, 2005 | III | IMN (n=24) | Femur | 15 months with reoperation; 3 months without reoperation | 30.0/10.0/7.0 | (10) |
| EPR (n=109) | ||||||
| ORIF (n=13) | ||||||
| Selek et al, 2008 | IV | EPR (n=45) | Femur | 11.5 | 27.2b | (8) |
| Present study | III | EPR (n=57) | Proximal femur | 9.0 | 25.3/12.8/8.1 | – |
| IMN (n=31) | ||||||
a
1-year/2-year survival rate
b
1-year survival rate. EPR, endoprosthetic replacement; IMN, intramedullary nailing; ORIF, open reduction and internal fixation.